Transjugular intrahepatic portosystemic shunts in liver transplant recipients

Liver International

Volumn 28, Issue 2, 2008, Pages 240-248

  Kim, John J ^a   Dasika, Narasimham L ^b   Yu, Esther ^a   Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Ascites; Liver transplant; Portal hypertension; Transjugularin trahepatic portosystemic shunt; Varices

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; ESOPHAGUS VARICES BLEEDING; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; INFECTION; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER GRAFT; MALE; OUTCOME ASSESSMENT; PARACENTESIS; PATIENT REFERRAL; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRESSURE GRADIENT; PUBLICATION; RETRANSPLANTATION; RETROSPECTIVE STUDY; SURVIVAL TIME; VENOUS PRESSURE;

ADOLESCENT; ADULT; AGED; ASCITES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SURVIVAL ANALYSIS;

EID: 38849088668     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01645.x     Document Type: Article

References (31)

1. Chapter VI. Liver and intestine transplantation in the United States, 1995-2004. HHS/HRSA/HSB/DOT, 2005 OPTN/SRTR Annual Report 1995-2004.
2. Wiesner RH, Sorrell M, Villamil F, et al. Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transplant 2003; 9 (Suppl.): 1-9.
3. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-22.
4. Dickson RC, Caldwell SH, Ishitani MB, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996; 61: 701-5.
5. Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29: 1220-6.
6. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 1999; 30: 612-22.
7. Boyer T, Haskal Z. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400.
8. Ochs A. Transjugular intrahepatic portosystemic shunt. Dig Dis 2005; 23: 56-64.
9. Amesur NB, Zajko AB, Orons PD, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Interv Radiol 1999; 10: 569-73.
10. Lerut JP, Goffette P, Molle G, et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation. Transplantation 1999; 68: 379-84.
11. Thuong VG, Funaki BS, Ehrhardt J, et al. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. Am J Roentgenol 2005; 184: 920-5.
12. Abouljoud M, Yoshida A, Kim D, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Transplant Proc 2005; 37: 1248-50.
13. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413-20.
14. Kerlan RK Jr, LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portosystemic shunts: Current status. Am J Roentgenol 1995; 164: 1059-66.
15. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
16. Sethi A, Stravitz RT. Review article: Medical management of the liver transplant recipient - a primer for non-transplant doctors. Ailment Pharmacol Ther 2007; 25: 229-445.
17. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: A retrospective analysis. Transplantation 1998; 66: 59-66.
18. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7.
19. Nazarian GK, Bjarnason H, Dietz CA Jr, et al. Refractory ascites: mid-term results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997; 205: 173-80.
20. Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2001; 12: 131-6.
21. Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003; 14 (Suppl.): S265-70.
22. Parrilla P, Sanchez-Bueno F, Figueras J, et al. Analysis of the complications of the piggy-back technique in 1,112 liver transplants. Transplantation 1999; 67: 1214-7.
23. Boyer TD, Vargus EV. Transjugular intrahepatic portosystemic shunt. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 9th edn. Philadelphia: Lippincott Williams & Williams, 2003; 369-82.
24. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art. Liver 1998; 18: 73-89.
25. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-71.
26. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP III, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology 1994; 20: 46-55.
27. Jalen R, Elton RA, Redead DN, Finalyasyon ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage. J Hepatology 1995; 23: 123-8.
28. Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138-44.
29. Patch D, Nicolopoulou V, McCormick A, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatology 1998; 28: 454-60.
30. Ferral H, Vasan R, Speeg KV, et al. Evaluation of model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol 2002; 13: 1103-8.
31. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory Model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98: 1167-74.